Albemarle Corporation (ALB) Income Statement Analysis

See more : Eve & Co Incorporated (EEVVF) Income Statement Analysis – Financial Results

Complete financial analysis of Albemarle Corporation (ALB) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Albemarle Corporation, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.

You may be interested

Interactive Health Network (IGRW) Income Statement Analysis – Financial Results
Sparinvest – Index Sektor Industri Kl (SPVBEUKL.CO) Income Statement Analysis – Financial Results
Garg Furnace Limited (GARGFUR.BO) Income Statement Analysis – Financial Results
PharmaEssentia Corporation (6446.TW) Income Statement Analysis – Financial Results
Local Bounti Corporation (LOCL) Income Statement Analysis – Financial Results

Albemarle Corporation (ALB)

Industry: Chemicals - Specialty

Sector: Basic Materials

Website: https://www.albemarle.com

About Albemarle Corporation

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, and disinfectants and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.

Metric	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995	1994	1993
Revenue	9.62B	7.32B	3.33B	3.13B	3.59B	3.37B	3.07B	2.68B	3.65B	2.45B	2.62B	2.75B	2.87B	2.36B	2.01B	2.47B	2.34B	2.37B	2.11B	1.51B	1.11B	980.22M	916.90M	917.55M	845.93M	820.86M	829.85M	854.48M	1.24B	1.08B	903.40M
Cost of Revenue	8.43B	4.25B	2.33B	2.13B	2.33B	2.16B	1.96B	1.71B	2.45B	1.67B	1.76B	1.84B	1.89B	1.62B	1.52B	1.86B	1.71B	1.82B	1.68B	1.20B	871.73M	744.98M	695.56M	646.09M	581.38M	560.06M	568.42M	611.35M	873.10M	742.10M	622.50M
Gross Profit	1.19B	3.07B	997.97M	994.85M	1.26B	1.22B	1.11B	970.58M	1.20B	770.85M	861.41M	910.00M	977.06M	745.92M	483.86M	607.67M	622.49M	550.81M	423.40M	312.35M	238.51M	235.24M	221.34M	271.46M	264.55M	260.81M	261.43M	243.13M	371.10M	338.80M	280.90M
Gross Profit Ratio	12.33%	42.00%	29.99%	31.80%	35.04%	36.07%	36.13%	36.25%	32.78%	31.52%	32.92%	33.15%	34.06%	31.57%	24.13%	24.63%	26.65%	23.26%	20.09%	20.63%	21.48%	24.00%	24.14%	29.59%	31.27%	31.77%	31.50%	28.45%	29.83%	31.34%	31.09%
Research & Development	85.73M	71.98M	54.03M	59.21M	58.29M	70.05M	84.33M	80.48M	102.87M	88.31M	82.25M	78.92M	77.08M	58.39M	60.92M	67.29M	62.69M	46.30M	41.68M	31.27M	18.41M	16.49M	21.92M	26.20M	34.29M	29.66M	31.45M	30.44M	29.50M	28.10M	0.00
General & Administrative	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Selling & Marketing	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
SG&A	919.49M	524.15M	441.48M	429.83M	533.37M	446.09M	437.90M	380.46M	512.27M	355.14M	162.89M	313.23M	312.14M	265.72M	225.02M	255.13M	244.97M	237.86M	219.73M	157.74M	117.23M	111.68M	98.92M	103.23M	105.44M	105.44M	109.27M	119.26M	130.50M	123.50M	143.80M
Other Expenses	-71.19M	86.36M	-603.34M	-59.18M	-45.48M	-64.43M	-25.60M	5.89M	48.47M	-16.76M	-6.92M	1.23M	0.00	0.00	12.39M	0.00	0.00	0.00	-1.90M	4.86M	10.05M	1.55M	2.05M	-8.13M	10.69M	0.00	0.00	0.00	94.10M	93.30M	88.50M
Operating Expenses	945.03M	596.13M	495.51M	489.04M	591.66M	516.14M	522.23M	460.94M	615.15M	443.45M	245.14M	392.15M	389.22M	324.12M	285.94M	360.97M	307.66M	284.16M	259.50M	193.87M	145.69M	129.71M	122.89M	121.30M	150.42M	135.09M	140.72M	149.70M	254.10M	244.90M	232.30M
Cost & Expenses	9.37B	4.84B	2.83B	2.62B	2.92B	2.67B	2.48B	2.17B	3.07B	2.12B	2.00B	2.23B	2.28B	1.94B	1.81B	2.22B	2.02B	2.10B	1.94B	1.40B	1.02B	874.69M	818.45M	767.39M	731.80M	695.15M	709.14M	761.06M	1.13B	987.00M	854.80M
Interest Income	0.00	103.75M	32.52M	73.12M	52.87M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	183.40K	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest Expense	116.07M	122.97M	61.48M	73.12M	57.70M	52.41M	115.35M	65.18M	132.72M	41.36M	31.56M	32.80M	37.57M	25.53M	24.58M	38.18M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation & Amortization	429.94M	300.84M	254.00M	231.98M	213.48M	200.70M	196.93M	226.17M	260.08M	103.57M	107.37M	99.02M	96.75M	95.58M	100.51M	111.69M	106.86M	112.95M	117.44M	97.27M	84.01M	80.60M	77.61M	73.75M	75.75M	75.01M	69.04M	71.04M	94.10M	93.30M	88.50M
EBITDA	792.75M	2.87B	875.13M	678.62M	943.25M	950.38M	843.55M	806.61M	652.47M	358.11M	683.36M	506.41M	684.95M	513.21M	285.37M	333.20M	420.37M	468.92M	281.33M	215.75M	176.84M	183.42M	176.06M	223.91M	200.60M	200.80M	189.80M	164.40M	211.10M	187.20M	137.10M
EBITDA Ratio	8.24%	39.15%	4.60%	21.69%	23.24%	18.86%	18.30%	19.26%	17.26%	12.70%	23.29%	18.91%	23.86%	17.85%	9.87%	10.00%	17.99%	19.80%	13.19%	16.80%	16.78%	18.80%	18.96%	23.15%	20.99%	24.26%	22.76%	0.27%	14.72%	16.41%	15.00%
Operating Income	251.88M	2.47B	-100.88M	505.81M	666.12M	911.54M	587.75M	574.55M	442.44M	271.30M	582.91M	406.16M	587.84M	414.85M	186.28M	220.92M	284.77M	145.16M	142.46M	71.84M	85.84M	103.81M	97.20M	147.50M	128.74M	122.80M	120.91M	253.08M	131.60M	89.40M	42.50M
Operating Income Ratio	2.62%	33.74%	-3.03%	16.17%	18.56%	27.01%	19.13%	21.46%	12.12%	11.09%	22.28%	14.79%	20.49%	17.56%	9.29%	8.95%	12.19%	6.13%	6.76%	4.75%	7.73%	10.59%	10.60%	16.08%	15.22%	14.96%	14.57%	29.62%	10.58%	8.27%	4.70%
Total Other Income/Expenses	-5.14M	-36.62M	-664.82M	-132.29M	-103.17M	-116.84M	-124.86M	-85.72M	-6.39M	-58.12M	-38.48M	-31.57M	-37.22M	-29.70M	-37.65M	-63.36M	-37.01M	-133.27M	-13.97M	-46.64M	-4.77M	-1.71M	-1.25M	-2.66M	3.90M	-3.00M	100.00K	159.70M	14.60M	-4.50M	-6.10M
Income Before Tax	246.74M	2.43B	133.62M	373.52M	562.95M	794.70M	446.80M	515.26M	358.19M	213.18M	544.43M	374.59M	550.62M	392.10M	160.27M	183.34M	277.82M	133.39M	149.93M	71.84M	88.06M	103.81M	97.20M	147.50M	128.74M	122.80M	120.91M	253.08M	131.60M	89.40M	42.50M
Income Before Tax Ratio	2.57%	33.24%	4.02%	11.94%	15.68%	23.55%	14.54%	19.25%	9.81%	8.72%	20.81%	13.64%	19.19%	16.60%	7.99%	7.43%	11.89%	5.63%	7.11%	4.75%	7.93%	10.59%	10.60%	16.08%	15.22%	14.96%	14.57%	29.62%	10.58%	8.27%	4.70%
Income Tax Expense	430.28M	390.59M	29.45M	54.43M	88.16M	144.83M	431.82M	96.26M	29.12M	18.48M	136.32M	82.53M	-130.01M	92.72M	-7.03M	-6.54M	55.08M	2.19M	27.59M	17.01M	13.89M	29.07M	29.03M	45.73M	39.91M	38.07M	40.92M	97.02M	53.40M	38.10M	20.70M
Net Income	1.57B	2.04B	123.67M	375.76M	533.23M	693.56M	54.85M	643.68M	334.91M	133.32M	413.17M	311.54M	436.28M	323.72M	178.37M	194.20M	229.69M	142.97M	114.87M	54.84M	71.95M	74.75M	68.17M	101.78M	88.83M	84.73M	79.98M	156.06M	78.20M	51.30M	21.80M
Net Income Ratio	16.36%	27.91%	3.72%	12.01%	14.86%	20.55%	1.79%	24.04%	9.17%	5.45%	15.79%	11.35%	15.21%	13.70%	8.89%	7.87%	9.83%	6.04%	5.45%	3.62%	6.48%	7.63%	7.43%	11.09%	10.50%	10.32%	9.64%	18.26%	6.29%	4.75%	2.41%
EPS	13.41	17.44	1.07	3.53	5.03	6.40	0.49	5.73	3.01	1.69	4.93	3.49	4.82	3.54	1.95	2.13	2.41	1.51	1.24	0.66	0.87	0.87	0.75	1.11	0.95	0.82	0.73	1.33	0.59	0.40	0.19
EPS Diluted	13.36	17.34	1.06	3.52	5.02	6.34	0.49	5.68	3.00	1.69	4.90	3.47	4.77	3.51	1.94	2.10	2.36	1.47	1.20	0.65	0.86	0.85	0.74	1.09	0.94	0.82	0.72	1.33	0.59	0.40	0.19
Weighted Avg Shares Out	117.32M	117.12M	115.84M	106.40M	105.95M	108.43M	110.91M	112.38M	111.18M	78.70M	83.84M	89.19M	90.52M	91.39M	91.51M	91.34M	95.25M	94.62M	92.70M	83.13M	82.51M	84.21M	91.53M	91.76M	93.78M	103.12M	110.34M	117.81M	132.54M	129.87M	117.84M
Weighted Avg Shares Out (Dil)	117.77M	117.79M	116.54M	106.81M	106.32M	109.46M	112.38M	113.24M	111.56M	79.10M	84.32M	89.88M	91.52M	92.18M	92.05M	92.53M	97.22M	97.14M	95.50M	85.05M	84.29M	86.27M	93.05M	93.21M	95.03M	104.27M	111.11M	117.81M	132.54M	129.87M	117.84M

Here's What Key Metrics Tell Us About Albemarle (ALB) Q3 Earnings

November 6, 2024zacks.com

Although the revenue and EPS for Albemarle (ALB) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Albemarle (ALB) Reports Q3 Loss, Misses Revenue Estimates

November 6, 2024zacks.com

Albemarle (ALB) came out with a quarterly loss of $1.55 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to earnings of $2.74 per share a year ago.

Albemarle loses more than $1 billion in Q3 on falling lithium prices

November 6, 2024reuters.com

Albemarle , the world's largest lithium producer, said on Thursday it lost more than $1 billion in the third quarter and that it would slash its capital budget amid a 71% drop in prices for the electric vehicle battery metal.

Albemarle Reports Third Quarter 2024 Results

November 6, 2024prnewswire.com

CHARLOTTE, N.C. , Nov. 6, 2024 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the third quarter ended September 30, 2024.

Albemarle to Report Q3 Earnings: What's in the Cards for the Stock?

November 5, 2024zacks.com

ALB is likely to have benefited from healthy lithium volumes and its cost and productivity actions in Q3 amid headwinds from softer lithium market prices.

Albemarle: Navigating Stormy Seas With Limited Visibility

November 5, 2024seekingalpha.com

Albemarle Corporation's stock remains a “Sell” due to declining revenue, profitability issues, and significant overvaluation despite a 17% price drop since January. Lithium prices have halved over the past year, leading to an oversupply and negative sentiment for Albemarle's upcoming...